# A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

> clinical trial · VERIFIED · 2026-06-24

Status: RECRUITING · Sponsor: Spectrum Pharmaceuticals, Inc · Condition: Solid Tumors

- Company: Spectrum Pharmaceuticals, Inc
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04570423

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.